Lamis Al Harby1,2,3, Mandeep S Sagoo1,2,3, Roderick O'Day1, Gordon Hay1,2,3, Amit K Arora1,2, Pearse A Keane2,3, Victoria M-L Cohen1,2, Bertil Damato1,4. 1. Ocular Oncology Service, Moorfields Eye Hospital, London, United Kingdom. 2. NIHR Biomedical Research Centre for Ophthalmology at Moorfields Eye Hospital and UCL Institute of Ophthalmology, London, United Kingdom. 3. University College London Institute of Ophthalmology, London, United Kingdom. 4. Nuffield Laboratory of Ophthalmology, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom.
Abstract
OBJECTIVE: The aim of this study was to determine the sensitivity and specificity of the MOLES scoring system in differentiating choroidal melanomas from nevi according to Mushroom shape, Orange pigment, Large tumor size, Enlarging tumor, and Subretinal fluid (SRF). METHODS: Color photographs, fundus-autofluorescence images, and optical coherence tomography of 222 melanocytic choroidal tumors were reviewed. Each MOLES feature was retrospectively scored between 0 and 2 and tumors categorized as "common nevus," "low-risk nevus," "high-risk nevus," and "probable melanoma" according to the total score. MOLES scores were compared with the experts' diagnosis of melanoma. RESULTS: The MOLES scoring system indicated melanoma in all 81 tumors diagnosed as such by ocular oncologists (100% sensitivity) and nevus in 135 of 141 tumors given this diagnosis by these experts (95.7% specificity). Of the 6 tumors with discordant diagnoses, 4 had basal diameters exceeding 6 mm, all with SRF and/or orange pigment, and 2 small tumors showed either significant SRF with traces of orange pigment, or vice versa. CONCLUSIONS: The MOLES system for diagnosing melanocytic choroidal tumors compares well with expert diagnosis but needs to be evaluated when deployed by ophthalmologists and community optometrists in a wide variety of working environments.
OBJECTIVE: The aim of this study was to determine the sensitivity and specificity of the MOLES scoring system in differentiating choroidal melanomas from nevi according to Mushroom shape, Orange pigment, Large tumor size, Enlarging tumor, and Subretinal fluid (SRF). METHODS: Color photographs, fundus-autofluorescence images, and optical coherence tomography of 222 melanocytic choroidal tumors were reviewed. Each MOLES feature was retrospectively scored between 0 and 2 and tumors categorized as "common nevus," "low-risk nevus," "high-risk nevus," and "probable melanoma" according to the total score. MOLES scores were compared with the experts' diagnosis of melanoma. RESULTS: The MOLES scoring system indicated melanoma in all 81 tumors diagnosed as such by ocular oncologists (100% sensitivity) and nevus in 135 of 141 tumors given this diagnosis by these experts (95.7% specificity). Of the 6 tumors with discordant diagnoses, 4 had basal diameters exceeding 6 mm, all with SRF and/or orange pigment, and 2 small tumors showed either significant SRF with traces of orange pigment, or vice versa. CONCLUSIONS: The MOLES system for diagnosing melanocytic choroidal tumors compares well with expert diagnosis but needs to be evaluated when deployed by ophthalmologists and community optometrists in a wide variety of working environments.
Authors: Sanket U Shah; Swathi Kaliki; Carol L Shields; Sandor R Ferenczy; Sarah A Harmon; Jerry A Shields Journal: Ophthalmology Date: 2012-01-31 Impact factor: 12.079
Authors: J William Harbour; Manuel Paez-Escamilla; Louis Cai; Scott D Walter; James J Augsburger; Zelia M Correa Journal: Am J Ophthalmol Date: 2018-09-07 Impact factor: 5.258
Authors: Lauren A Dalvin; Carol L Shields; David Arturo Ancona-Lezama; Michael D Yu; Maura Di Nicola; Basil K Williams; J Antonio Lucio-Alvarez; Su Mae Ang; Sean M Maloney; R Joel Welch; Jerry A Shields Journal: Br J Ophthalmol Date: 2018-12-06 Impact factor: 4.638
Authors: Daniel L Albertus; Ira H Schachar; Sarwar Zahid; Victor M Elner; Hakan Demirci; Thiran Jayasundera Journal: JAMA Ophthalmol Date: 2013-08 Impact factor: 7.389
Authors: Kelsey A Roelofs; Roderick O'Day; Lamis Al Harby; Amit K Arora; Victoria M L Cohen; Mandeep S Sagoo; Bertil Damato Journal: Cancers (Basel) Date: 2020-05-21 Impact factor: 6.639
Authors: Fredy Geiger; Sadiq Said; Anahita Bajka; Mario Damiano Toro; Maximilian Robert Justus Wiest; Marc Stahel; Daniel Barthelmes; Sandrine Anne Zweifel Journal: Curr Oncol Date: 2022-02-11 Impact factor: 3.677